BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gembillo G, Sessa C, Santoro D. Cystatin C-based equations: Enhancing accuracy in kidney function tests for type 2 diabetes. World J Nephrol 2025; 14(3): 102756 [PMID: 41024961 DOI: 10.5527/wjn.v14.i3.102756]
URL: https://www.wjgnet.com/2220-6124/full/v14/i3/102756.htm
Number Citing Articles
1
Bodour S. Rajab, Ahmed M. El-Sebaey, Anmar A. Khan, Talat A. Albukhari, Bassem Refaat, Hatem A. Sembawa, Rehab M. Bagadood, Eyad T. Albukhari, Nani Nasreldin, Mohamed E. El-Boshy. Edaravone Improves the Efficacy of Metformin Against Diabetic Nephropathy by Attenuating Inflammation, Oxidative Stress, and Apoptosis with Associated Modulation of MAPK/NF-κB1 and AKT/NRF2 Pathways in Rats. Biology 2026; 15(21) doi: 10.3390/biology15211988
2
Harish G Bagewadi, Sachin Patil, Manjushree Sugoor, Renuka S Melkundi, Shivalee A, Rohini Kallur, Sangamesh B Tondare. Evaluation of Serum Adipocytokines and Cystatin C As Early Biomarkers in Chronic Kidney Disease Patients and Their Relation to Endothelial Dysfunction. Cureus 2026;  doi: 10.7759/cureus.109069
3
Concetto Sessa, Guido Gembillo, Walter Morale. Rethinking chronic kidney disease risk after liver transplantation. World Journal of Transplantation 2026; 16(2): 115035 doi: 10.5500/wjt.v16.i2.115035
4
Guido Gembillo, Luca Visconti, Valeria Tranchida, Chiara Nardi, Sebastiano Calimeri, Maria Elsa Gambuzza, Maria Princiotto, Chiara Chinigo, Luca Soraci, Domenico Santoro. Evolving strategies for nephroprotection in diabetic kidney disease: From established therapies to novel interventions. World Journal of Diabetes 2026; 17(4): 115058 doi: 10.4239/wjd.v17.i4.115058
5
Pranjal Kashiv, Khushboo Saxena, Manish Ramesh Balwani, Vivek B Kute. Reply: Chronic kidney disease after liver transplantation: Accurate measurement, early acute kidney injury, and renal-protective strategies. World Journal of Transplantation 2026; 16(3): 124182 doi: 10.5500/wjt.124182